Friday, July 10, 2026

pharma · acute pharyngitis

MEDICE Arzneimittel Pütter

MEDICE Arzneimittel Pütter clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Iserlohn, DE HQ
1949 Founded
600 Employees
EMA registrant Type
Company details
Status
Public
HQ
Iserlohn, DE
Founded
1949
Employees
600
Programs
3
Drugs
6
Patents
0
Intelligence · Clinical Programs

MEDICE Arzneimittel Pütter projects

3 ClinicalTrials.gov programs sponsored by MEDICE Arzneimittel Pütter.

MEDICE Arzneimittel Pütter has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 6520-9970-08

    Medice Arzneimittel Pütter GmbH & Co. KG

    Patients with ADHD (according to ICD-10 / DSM-5)

    phase 3 small molecule active

    1 trial
  2. 6630-9450-01

    Medice Arzneimittel Pütter GmbH & Co. KG

    acute pharyngitis

    phase 3 small molecule active

    1 trial
  3. 6630-9450-01

    Medice Arzneimittel Pütter GmbH & Co. KG

    acute pharyngitis

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does MEDICE Arzneimittel Pütter have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.